title: [Kidney injury biomarkers].
abstract: Over the last few decades, prevalence of renal diseases has grown continuously in occidental societies due to life conditions (age, life style, chronic disease, etc.) or potential exposure to nephrotoxic agents (drugs and environmental chemicals). Today, the knowledge of the nephropatology mechanism is improving. Nevertheless, considering it is a complex and multifunctional structure, the clinical strategy of this issue (prognostic, diagnostic or therapy) keeps posing a major challenge for clinicians mostly because classical markers are not sensitive enough and require hours before reaching significant levels. Furthermore, most of these markers provide information on function and not on structural integrity of the tissue. Identification and development of new biomarkers share promise of improvement in the rapid diagnostic of kidney diseases and development of new cures in order to optimize the clinical strategy associated to the renal failure.
authors.affiliation: PRP-HOM, SRBE, laboratoire de radiotoxicologie expérimentale (LRTOX), Institut de radioprotection et de sureté nucléaire (IRSN), Fontenay-aux-Roses, France. yann.gueguen@irsn.fr
authors.forename: Yann
authors.initials: Y
authors.lastname: Gueguen
authors.forename: Caroline
authors.initials: C
authors.lastname: Rouas
authors.forename: François A
authors.initials: FA
authors.lastname: Leblond
mesh_terms: D015415:Biomarkers / Q000032:analysis; D006801:Humans; D007674:Kidney Diseases / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis* / Q000652:urine
chemical_list: D015415:Biomarkers